Evaluation of the medical curriculum:: Why, when, by whom and for whom should questionnaires be used

被引:15
|
作者
Pabst, R [1 ]
Nave, H [1 ]
Rothkötter, HJ [1 ]
Tschernig, T [1 ]
机构
[1] Hannover Med Sch, D-30625 Hannover, Germany
来源
EUROPEAN JOURNAL OF MORPHOLOGY | 2001年 / 39卷 / 04期
关键词
D O I
10.1076/ejom.39.4.237.4662
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The undergraduate medical curriculum has been modified or even totally reorganized in many countries in recent years, and there are plans to make departmental budgets and the salaries of university professors partially dependent on the outcome of teaching. Questionnaires are often used in such situations as a means of curriculum evaluation. Based on our own experience such evaluations should be done not only during and immediately after a course in the curriculum, but also at later time points, e.g., at the end of the undergraduate and also the postgraduate phase. The clinical relevance of lectures and courses can only be graded adequately after some years of clinical experience. Gross anatomy was graded top at all time points evaluated and reached higher levels of 'clinical relevance' than other typical preclinical and even clinical subjects. Efforts should be made to obtain a high response rate for representative results. After modifying parts of a course detailed questionnaires should also include space for students' suggestions. The results of such evaluations are not only relevant to the head of department as feedback on the individual lecturers but also important for the curriculum committee and the dean. Anatomists should utilize these evaluations to improve teaching.
引用
收藏
页码:237 / 239
页数:3
相关论文
共 50 条
  • [1] When, for How Long and in Whom Should Medical Expulsive Therapy be Used?
    Monga, Manoj
    [J]. JOURNAL OF UROLOGY, 2014, 191 (03): : 581 - 581
  • [2] Making sense of refractive surgery in 2001: Why, when, for whom, and by whom?
    Mannis, MJ
    Segal, WA
    Darlington, JK
    [J]. MAYO CLINIC PROCEEDINGS, 2001, 76 (08) : 823 - 829
  • [3] When should adrenaline be given and by whom?
    Dreborg, Sten
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2013, 24 (01) : 97 - 98
  • [4] Size matters but when, why and for whom?
    Blackwell, Anna K. M.
    Lee, Ilse
    Scollo, Michelle
    Wakefield, Melanie
    Munafo, Marcus R.
    Marteau, Theresa M.
    [J]. ADDICTION, 2020, 115 (05) : 815 - 816
  • [5] Dyslipidemia testing: Why, for whom and when
    Galema-Boers, J. M. H.
    van Lennep, J. E. Roeters
    [J]. MATURITAS, 2015, 81 (04) : 442 - 445
  • [6] Evaluation: Why, for Whom and How?
    Lucas, Henry
    Longhurst, Richard
    [J]. IDS BULLETIN-INSTITUTE OF DEVELOPMENT STUDIES, 2010, 41 (06): : 28 - 35
  • [7] Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
    Demichelis-Gomez, Roberta
    Perez-Samano, Daniela
    Bourlon, Christianne
    [J]. CURRENT ONCOLOGY REPORTS, 2019, 21 (02)
  • [8] Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
    Roberta Demichelis-Gómez
    Daniela Pérez-Sámano
    Christianne Bourlon
    [J]. Current Oncology Reports, 2019, 21
  • [9] Tranexamic acid for childbirth: why, when, and for whom
    Sentilhes, Loic
    Madar, Hugo
    Mattuizzi, Aurelien
    Froeliger, Alizee
    Merlot, Benjamin
    Elleboode, Benoit
    Deneux-Tharaux, Catherine
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (09) : 753 - 761
  • [10] Advanced Lipid Testing: When, Why, and In Whom?
    Watson, Karol E.
    Stocker, Eric H.
    Jacoby, Douglas S.
    McCullough, Peter A.
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (04) : 311 - 319